Health Products

Teva Canada Product Recall (2018-11-23)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDosage formDIN, NPN, DIN-HIMStrength
35439807AB. Novamoxin Granules for Oral Suspension 250mg/5mL
Recalling Firm
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Granules for suspensionDIN 00452130Amoxicillin 250mg/5mL
35438292B, 35438811AA. Novamoxin Granules for Oral Suspension 125mg/5mL
Recalling Firm
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Granules for suspensionDIN 00452149Amoxicillin 125mg/5mL

Introduction

Recalled Product

A. Novamoxin Granules for Oral Suspension 125mg/5mL

B. Novamoxin Granules for Oral Suspension 250mg/5mL

Reason

Out of specification results for homogeneity.

Depth of distribution

Retailers
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime